Current Progress in Drug Target Identification and Drug Delivery
Xin Wang
Author Information
Faculty of Biology, Medicine, and Health, University of Manchester, Oxford Road, M13 9PT Manchester, UK
* Correspondence: xin.wang@manchester.ac.uk
Received: 05 Dec 2022 | Accepted: 07 Dec 2022 | Published: 21 Dec 2022
References
1.
Wang S.; Wang Z.; Fang L.;et al. Advances of the target-based and phenotypic screenings and strategies in drug discovery. International Journal of Drug Discovery and Pharmacology,2022,1(1),2. https://doi.org/10.53941/ijddp.v1i1.199.
2.
Song Y.; Woo A.; Zhang Y.; et al.Cardiac β-adrenoceptor signaling: the new insight on an old target in the therapy of cardiovascular disease. International Journal of Drug Discovery and Pharmacology,2022,1(1),3. https://doi.org/10.53941/ijddp.v1i1.177.
3.
Langa P.; Wolska B.; Solaro R.The hippo signaling pathway as a drug target in familial dilated cardiomyopathy. International Journal of Drug Discovery and Pharmacology,2022,1(1),4. https://doi.org/10.53941/ijddp.v1i1.189.
4.
Xu H.; Wang D.; Ramponi C.;et al. The P21-activated kinase 1 and 2 as potential therapeutic targets for the management of cardiovascular disease.International Journal of Drug Discovery and Pharmacology,2022,1(1),5. https://doi.org/10.53941/ijddp.v1i1.179.
5.
Song W.H.; Sun W.; Wang Z.L.; et al.Targeting inflammation to control tissue fibrosis. International Journal of Drug Discovery and Pharmacology,2022,1(1),6. https://doi.org/10.53941/ijddp.v1i1.206
6.
Zhou Y.; Chen C. From Bench to Bedside: Current Developments in RNA-Based Therapies for Treatment of Hyperlipidemia. International Journal of Drug Discovery and Pharmacology,2022,1(1),7. https://doi.org/10.53941/ijddp.v1i1.141.
7.
Zhou Z.; Wang D.; Wu J. Role of sodium glucose cotransporter 2 inhibitor in hypertension. International Journal of Drug Discovery and Pharmacology,2022,1(1),8. https://doi.org/10.53941/ijddp.v1i1.175.
8.
Liu Y.; Xu H.; Abraham S.; et al. Progress of 3D organoid technology for preclinical investigations: towards human in vitro models. International Journal of Drug Discovery and Pharmacology,2022,1(1),9. https://doi.org/10.53941/ijddp.v1i1.188.
9.
Bai X.; Tirella A. Injectable multifunctional natural polymer-based hydrogels for the local delivery of therapeutic agents. International Journal of Drug Discovery and Pharmacology,2022,1(1),10. https://doi.org/10.53941.ijddp.v1i1.203.
10.
Liu M.; Ramponi C.; Fan X.;et al. Nanoparticle-based drug delivery system for post myocardial infarction management. International Journal of Drug Discovery and Pharmacology,2022,1(1),11. https://doi.org/10.53941/ijddp.v1i1.171.
Wang, X. Current Progress in Drug Target Identification and Drug Delivery. International Journal of Drug Discovery and Pharmacology2022, 1 (1), 1. https://doi.org/10.53941/ijddp.v1i1.214.
Wang S.; Wang Z.; Fang L.;et al. Advances of the target-based and phenotypic screenings and strategies in drug discovery. International Journal of Drug Discovery and Pharmacology,2022,1(1),2. https://doi.org/10.53941/ijddp.v1i1.199.
2.
Song Y.; Woo A.; Zhang Y.; et al.Cardiac β-adrenoceptor signaling: the new insight on an old target in the therapy of cardiovascular disease. International Journal of Drug Discovery and Pharmacology,2022,1(1),3. https://doi.org/10.53941/ijddp.v1i1.177.
3.
Langa P.; Wolska B.; Solaro R.The hippo signaling pathway as a drug target in familial dilated cardiomyopathy. International Journal of Drug Discovery and Pharmacology,2022,1(1),4. https://doi.org/10.53941/ijddp.v1i1.189.
4.
Xu H.; Wang D.; Ramponi C.;et al. The P21-activated kinase 1 and 2 as potential therapeutic targets for the management of cardiovascular disease.International Journal of Drug Discovery and Pharmacology,2022,1(1),5. https://doi.org/10.53941/ijddp.v1i1.179.
5.
Song W.H.; Sun W.; Wang Z.L.; et al.Targeting inflammation to control tissue fibrosis. International Journal of Drug Discovery and Pharmacology,2022,1(1),6. https://doi.org/10.53941/ijddp.v1i1.206
6.
Zhou Y.; Chen C. From Bench to Bedside: Current Developments in RNA-Based Therapies for Treatment of Hyperlipidemia. International Journal of Drug Discovery and Pharmacology,2022,1(1),7. https://doi.org/10.53941/ijddp.v1i1.141.
7.
Zhou Z.; Wang D.; Wu J. Role of sodium glucose cotransporter 2 inhibitor in hypertension. International Journal of Drug Discovery and Pharmacology,2022,1(1),8. https://doi.org/10.53941/ijddp.v1i1.175.
8.
Liu Y.; Xu H.; Abraham S.; et al. Progress of 3D organoid technology for preclinical investigations: towards human in vitro models. International Journal of Drug Discovery and Pharmacology,2022,1(1),9. https://doi.org/10.53941/ijddp.v1i1.188.
9.
Bai X.; Tirella A. Injectable multifunctional natural polymer-based hydrogels for the local delivery of therapeutic agents. International Journal of Drug Discovery and Pharmacology,2022,1(1),10. https://doi.org/10.53941.ijddp.v1i1.203.
10.
Liu M.; Ramponi C.; Fan X.;et al. Nanoparticle-based drug delivery system for post myocardial infarction management. International Journal of Drug Discovery and Pharmacology,2022,1(1),11. https://doi.org/10.53941/ijddp.v1i1.171.